BioWorld MedTech

July 8, 2013

An Advance Worth Drinking To: Functional, if still tiny, human liver created from stem cells

Starting with induced pluripotent stem cells (iPSCs), scientists have created the first artificial organ – a functional liver bud, which is the precursor to the mature liver that is normally formed early in embryonic development. Read More

TMS seeks to improve monitoring in ICU via variability analysis

Researchers develop telescope-like contact lens for AMD patients

Washington roundup: AMA urges obesity-as-disease approach; BMI as Dx an issue

Financings roundup: GI Dynamics completes its $57.5M private placement

International report: Guided Therapeutics to place LuViva in Turkey

Agreements/contracts: OptiNose to deliver Avanir's sumatriptan

HIT roundup: Washington hospital launches WeCare EHR system from Epic

Court report: Baxano reaches final agreement with DoJ regarding subpoena

Holiday Notice

Product Briefs

Med-Tech Notes

People in the News

MDD's Neurology Extra

MDD's Financial Roundup (Q213) Deals roundup: Device firms report/close 15 deals in 2Q13 worth $29B

Financings roundup: Second quarter sees drop off compared to first part of 2013

Washington roundup: SCOTUS says no to isolated DNA, but cDNA still eligible

Agreements/contracts: Numbers drop a little; but innovation, and coverage, continues

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...